Rosalind Advisors’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17M Buy
2,045,644
+262,800
+15% +$2.18M 8.05% 2
2025
Q1
$10.9M Buy
1,782,844
+522,968
+42% +$3.18M 5.28% 6
2024
Q4
$7.96M Buy
+1,259,876
New +$7.96M 4.07% 10